Scholars Central

EditorialPublished 23 Jul 2022

MiRNAs related with the cell cycle as targets and therapies in lung cancer treatment

Authors: Jason Burns

European Journal of Clinical Oncology

Volume 4 · Issue 4 · Pages 48–49

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Lung cancer is the leading cause of cancer deaths worldwide. The main obstacles to this cancer's clinical success are limited therapy alternatives and resistance to existing medications. Several studies over the last decade have demonstrated the significance of microRNA (miRNA) driven cell cycle regulation in lung cancer growth. As a result, these tiny nucleotide compounds could be useful in lung cancer therapy. We highlighted current advances in lung cancer therapy employing cell cycle associated miRNAs in this review. By emphasizing the roles of particular cell cycle core regulators associated with miRNAs in lung cancer, we explained how these miRNAs might be investigated in early detection and therapy efforts to avoid lung cancer. More medical efforts can ensure a potential breakthrough in miRNA-based lung cancer therapy with the information provided in our review.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in European Journal of Clinical Oncology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEuropean Journal of Clinical Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jason Burns”